Skip to main content
. 2020 Oct;9(5):1904–1914. doi: 10.21037/tlcr-20-522

Figure S1.

Figure S1

MTS analysis of cell viability for parental cells treated with increasing concentrations of capmatinib or crizotinib with or without 5 µM erlotinib. All values are normalized to the value of the untreated sample of each individual cell line.